Annika Vestergaard Kvist

Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)

Annika Vestergaard Kvist, Junaid Faruque, Enriqueta Vallejo‐Yagüe et al. · Journal of Clinical Medicine · 2021 · 84 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Site-Specific Fracture Incidence Rates Among Patients With Type 1 Diabetes, Type 2 Diabetes, or Without Diabetes in Denmark (1997–2017)

Annika Vestergaard Kvist, Mohamad I. Nasser, Peter Vestergaard et al. · Diabetes Care · 2023 · 30 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +15

Bone parameters in T1D and T2D assessed by DXA and HR-pQCT – A cross-sectional study: The DIAFALL study

Nicklas H. Rasmussen, Jakob Dal, Annika Vestergaard Kvist et al. · Bone · 2023 · 27 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +15

Impaired postural control in diabetes—a predictor of falls?

Nicklas H. Rasmussen, Jakob Dal, Morten Hasselstrøm Jensen et al. · Archives of Osteoporosis · 2022 · 26 citations · Full text

Medicine, Orthopaedic Surgery, Physical Medicine +12